Legal & General Group
OKUR

Legal & General Group’s OnKure Therapeutics OKUR Stock Holding History

Legal & General Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Buy
+2,555
New +$11K ﹤0.01% 3288
2024
Q2 		– Sell
-142
Closed -$2.35K – 3523
2024
Q1 		$2.35K Hold
142
– – ﹤0.01% 3339
2023
Q4 		$2.27K Buy
142
+28
+25% +$1.75K ﹤0.01% 3363
2023
Q3 		$8.68K Hold
114
– – ﹤0.01% 3294
2023
Q2 		$7.48K Buy
+114
New +$9.18K ﹤0.01% 3348
2022
Q2 		– Sell
-70
Closed -$2K – 3684
2022
Q1 		$2K Hold
70
– – ﹤0.01% 3553
2021
Q4 		$6K Buy
70
+14
+25% +$1.03K ﹤0.01% 3538
2021
Q3 		$4K Sell
56
-15
-21% -$1.27K ﹤0.01% 3489
2021
Q2 		$7K Buy
+71
New +$7.92K ﹤0.01% 3448

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's OKUR Position: Q2 2026 in Review

Legal & General Group opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 2,555 shares worth $11.7K. The stake represents ﹤0.01% of the portfolio and ranks #3288 among its holdings. This is a return to the name: Legal & General Group previously reported a position in OKUR as recently as Q1 2024.

Legal & General Group first reported a position in OKUR in Q2 2021 and has held it in 9 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Legal & General Group held 2,555 shares of OnKure Therapeutics worth $11.7K as of Q2 2026.
  • OnKure Therapeutics was a new Legal & General Group position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3288 holding.
  • Legal & General Group first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 9 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.